NO20010318L - Fremgangsmåte for fremstilling av Citalopram - Google Patents

Fremgangsmåte for fremstilling av Citalopram

Info

Publication number: NO20010318L
Authority: NO; Norway
Prior art keywords: citalopram; preparation
Prior art date: 1999-06-25

Application number

NO20010318A

Other languages

English (en)

Other versions

NO20010318D0 (no

Inventor

Hans Peterson

Michael Harold Rock

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-25

Filing date

2001-01-19

Publication date

2001-02-20

2001-01-19 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2001-01-19 Publication of NO20010318D0 publication Critical patent/NO20010318D0/no

2001-02-20 Publication of NO20010318L publication Critical patent/NO20010318L/no

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/847—Nickel

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Inorganic Chemistry (AREA)
Materials Engineering (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)
Furan Compounds (AREA)

NO20010318A 1999-06-25 2001-01-19 Fremgangsmåte for fremstilling av Citalopram NO20010318L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA199900921		1999-06-25
PCT/DK1999/000643 WO2000011926A2 (en)	1999-06-25	1999-11-19	Method for the preparation of citalopram

Publications (2)

Publication Number	Publication Date
NO20010318D0 NO20010318D0 (no)	2001-01-19
NO20010318L true NO20010318L (no)	2001-02-20

Family

ID=8099044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20010318A NO20010318L (no)	1999-06-25	2001-01-19	Fremgangsmåte for fremstilling av Citalopram

Country Status (36)

Country	Link
US (1)	US6750358B2 (no)
EP (1)	EP1105382B1 (no)
JP (1)	JP3389571B2 (no)
KR (1)	KR100491369B1 (no)
CN (1)	CN1129593C (no)
AR (1)	AR020573A1 (no)
AT (3)	ATE213237T1 (no)
AU (2)	AU1374800A (no)
BG (1)	BG106190A (no)
BR (1)	BR9917367A (no)
CA (1)	CA2290125C (no)
CH (1)	CH691304A5 (no)
CZ (1)	CZ292174B6 (no)
DE (2)	DE19983486C2 (no)
DK (1)	DK1105382T3 (no)
EA (1)	EA002661B1 (no)
ES (1)	ES2172356T3 (no)
FI (1)	FI108538B (no)
GB (1)	GB2354240B (no)
HK (1)	HK1047745B (no)
HU (1)	HUP0103417A3 (no)
IL (1)	IL145960A0 (no)
IS (1)	IS5862A (no)
IT (1)	ITMI991579A1 (no)
MX (1)	MXPA01010986A (no)
NO (1)	NO20010318L (no)
NZ (1)	NZ514982A (no)
PL (1)	PL345971A1 (no)
PT (1)	PT1105382E (no)
SE (1)	SE516689C2 (no)
SI (1)	SI1105382T1 (no)
SK (1)	SK18412001A3 (no)
TR (1)	TR200103700T2 (no)
UA (1)	UA62023C2 (no)
WO (1)	WO2000011926A2 (no)
ZA (1)	ZA200108855B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002533450A (ja)	1998-12-23	2002-10-08	ハー・ルンドベック・アクチエゼルスカベット	５−シアノフタリドの製造方法
AR022329A1 (es)	1999-01-29	2002-09-04	Lundbeck & Co As H	Metodo para la preparacion de 5-cianoftalida
HU227473B1 (en)	1999-04-14	2011-07-28	Lundbeck & Co As H	Method for preparation of citalopram
ITMI991581A1 (it) *	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
ITMI991579A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
SK287139B6 (sk)	1999-10-25	2010-01-07	H. Lundbeck A/S	Spôsob prípravy citalopramu
SI1228056T1 (en)	1999-10-25	2005-02-28	H. Lundbeck A/S	Method for the preparation of citalopram
AR026063A1 (es)	1999-11-01	2002-12-26	Lundbeck & Co As H	Metodo para la preparacion de 5-carboxiftalida.
MXPA02006503A (es)	1999-12-28	2002-12-09	Lundbeck & Co As H	Metodo para la preparacion de citalopram.
BR9917604A (pt)	1999-12-30	2002-12-31	Lundbeck & Co As H	Método para preparação de citalopram
ATE252570T1 (de)	2000-01-14	2003-11-15	Lundbeck & Co As H	Verfahren zur herstellung von 5-cyanophthalid
NL1017415C1 (nl)	2000-02-24	2001-05-18	Lundbeck & Co As H	Werkwijze voor de bereiding van Citalopram.
NL1017417C1 (nl)	2000-03-03	2001-03-16	Lundbeck & Co As H	Werkwijze voor de bereiding van Citalopram.
GB0005477D0 (en)	2000-03-07	2000-04-26	Resolution Chemicals Limited	Process for the preparation of citalopram
GB2357762B (en)	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
PL360110A1 (en)	2000-03-13	2004-09-06	H.Lundbeck A/S	Method for the preparation of citalopram
IES20010206A2 (en)	2000-03-13	2002-03-06	Lundbeck & Co As H	Method for the preparation of citalopram
NZ521204A (en)	2000-03-13	2004-03-26	H	Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)- 1,3-dihydroisobenzofurans for preparing citalopram, an anti depressant
EP1265882B1 (en)	2000-03-14	2004-01-14	H. Lundbeck A/S	Method for the preparation of citalopram
TR200202168T2 (tr) *	2000-03-16	2002-12-23	H. Lundbeck A/S	5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
AR032455A1 (es)	2000-05-12	2003-11-12	Lundbeck & Co As H	Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
AU2001272368A1 (en) *	2000-07-06	2002-01-21	H. Lundbeck, A/S	Method for the preparation of citalopram
CA2354880C (en)	2000-08-18	2003-06-03	H. Lundbeck A/S	Method for the preparation of citalopram
ES2228824T3 (es)	2000-12-22	2005-04-16	H. Lundbeck A/S	Metodo de preparacion de citalopram puro.
CA2359810C (en) *	2000-12-28	2002-11-05	H. Lundbeck A/S	Process for the preparation of pure citalopram
CA2435925A1 (en)	2001-01-30	2002-08-08	Orion Corporation Fermion	Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
GB0105627D0 (en) *	2001-03-07	2001-04-25	Cipla Ltd	Preparation of phthalanes
WO2002072565A1 (en) *	2001-03-09	2002-09-19	Ranbaxy Laboratories Limited	Process for the preparation of citalopram
DK1522539T3 (da) *	2001-07-31	2007-05-07	Lundbeck & Co As H	Krystallinsk komposition indeholdende excitalopram
WO2003057132A2 (en)	2002-01-07	2003-07-17	Sun Pharmaceutical Industries Limited	Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
TWI306846B (en)	2002-08-12	2009-03-01	Lundbeck & Co As H	Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050154052A1 (en) *	2003-03-24	2005-07-14	Hetero Drugs Limited	Novel crystalline forms of (s)-citalopram oxalate
EP1486492A3 (en) *	2003-06-10	2005-02-23	Sun Pharmaceuticals Industries Ltd.	A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
TWI339651B (en)	2004-02-12	2011-04-01	Lundbeck & Co As H	Method for the separation of intermediates which may be used for the preparation of escitalopram
JP2006008603A (ja) *	2004-06-25	2006-01-12	Sumitomo Chemical Co Ltd	光学活性シタロプラムの製造方法、その中間体およびその製造方法
KR101166280B1 (ko)	2004-08-23	2013-11-27	썬 파마 글로벌 에프제트이	시탈로프램 및 에난티오머의 제조 방법
WO2006103550A1 (en) *	2005-03-31	2006-10-05	Ranbaxy Laboratories Limited	Processes for the preparation of citalopram and its intermediate 5-aminophthalide
TWI358407B (en)	2005-06-22	2012-02-21	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersibl
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (en)	2007-07-06	2009-01-21	Aurobindo Pharma Limited	Process for the preparation of escitalopram

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143703A (no)	1965-03-18
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en)	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8814057D0 (en)	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
CA2010159A1 (en)	1989-02-21	1990-08-21	James J. Maul	Cyanation of haloaromatics utilizing catalysts generated in situ starting with nic1 or nic1 6h 0
US5296507A (en)	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
DE19626659A1 (de)	1996-07-03	1998-01-08	Basf Ag	Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de)	1996-07-10	1998-01-15	Basf Ag	Verfahren zur Herstellung von Phthaliden
DE19706648A1 (de)	1997-02-20	1998-08-27	Bayer Ag	Verfahren zur Herstellung von aromatischen Nitrilen
CN1206207C (zh)	1997-07-08	2005-06-15	H.隆德贝克有限公司	氰酞氟苯胺的制备方法
UA62985C2 (en)	1997-11-10	2004-01-15	Lunnbeck As H	A method for the preparation of citalopram
SK283907B6 (sk)	1997-11-11	2004-04-06	H. Lundbeck A/S	Spôsob výroby citalopramu a medziprodukty
PL199423B1 (pl)	1998-10-20	2008-09-30	Lundbeck & Co As H	Sposób wytwarzania citalopramu
JP2002533450A (ja)	1998-12-23	2002-10-08	ハー・ルンドベック・アクチエゼルスカベット	５−シアノフタリドの製造方法
AR022329A1 (es)	1999-01-29	2002-09-04	Lundbeck & Co As H	Metodo para la preparacion de 5-cianoftalida
DE10015280A1 (de)	1999-03-29	2001-01-04	Nissan Chemical Ind Ltd	Verfahren zur Herstellung von Benzonitrilverbindungen
HU227473B1 (en)	1999-04-14	2011-07-28	Lundbeck & Co As H	Method for preparation of citalopram
ITMI991581A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
ITMI991579A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
SK287139B6 (sk)	1999-10-25	2010-01-07	H. Lundbeck A/S	Spôsob prípravy citalopramu
US6310222B1 (en)	1999-11-01	2001-10-30	Sumika Fine Chemicals Co., Ltd.	Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
GB0005477D0 (en)	2000-03-07	2000-04-26	Resolution Chemicals Limited	Process for the preparation of citalopram
ES2228824T3 (es)	2000-12-22	2005-04-16	H. Lundbeck A/S	Metodo de preparacion de citalopram puro.
CA2359810C (en)	2000-12-28	2002-11-05	H. Lundbeck A/S	Process for the preparation of pure citalopram

1999
- 1999-07-15 IT IT1999MI001579A patent/ITMI991579A1/it unknown
- 1999-11-19 CH CH00307/01A patent/CH691304A5/de not_active IP Right Cessation
- 1999-11-19 AT AT99968206T patent/ATE213237T1/de not_active IP Right Cessation
- 1999-11-19 AT AT0904099A patent/AT409960B/de not_active IP Right Cessation
- 1999-11-19 AU AU13748/00A patent/AU1374800A/en active Pending
- 1999-11-19 NZ NZ514982A patent/NZ514982A/xx unknown
- 1999-11-19 DE DE19983486T patent/DE19983486C2/de not_active Expired - Fee Related
- 1999-11-19 SK SK1841-2001A patent/SK18412001A3/sk unknown
- 1999-11-19 GB GB0101508A patent/GB2354240B/en not_active Expired - Fee Related
- 1999-11-19 ES ES99968206T patent/ES2172356T3/es not_active Expired - Lifetime
- 1999-11-19 CN CN99816768A patent/CN1129593C/zh not_active Expired - Fee Related
- 1999-11-19 IL IL14596099A patent/IL145960A0/xx unknown
- 1999-11-19 BR BR9917367-0A patent/BR9917367A/pt not_active IP Right Cessation
- 1999-11-19 TR TR2001/03700T patent/TR200103700T2/xx unknown
- 1999-11-19 DE DE69900891T patent/DE69900891D1/de not_active Expired - Lifetime
- 1999-11-19 HK HK02109330.8A patent/HK1047745B/zh not_active IP Right Cessation
- 1999-11-19 EP EP99968206A patent/EP1105382B1/en not_active Expired - Lifetime
- 1999-11-19 HU HU0103417A patent/HUP0103417A3/hu unknown
- 1999-11-19 DK DK99968206T patent/DK1105382T3/da active
- 1999-11-19 SI SI9930039T patent/SI1105382T1/xx unknown
- 1999-11-19 PL PL99345971A patent/PL345971A1/xx not_active Application Discontinuation
- 1999-11-19 WO PCT/DK1999/000643 patent/WO2000011926A2/en not_active Ceased
- 1999-11-19 PT PT99968206T patent/PT1105382E/pt unknown
- 1999-11-19 KR KR10-2001-7013971A patent/KR100491369B1/ko not_active Expired - Fee Related
- 1999-11-19 UA UA2001117897A patent/UA62023C2/uk unknown
- 1999-11-19 MX MXPA01010986A patent/MXPA01010986A/es not_active IP Right Cessation
- 1999-11-19 AU AU2001100433A patent/AU2001100433B4/en not_active Ceased
- 1999-11-19 EA EA200101071A patent/EA002661B1/ru not_active IP Right Cessation
- 1999-11-19 CZ CZ2001319A patent/CZ292174B6/cs not_active IP Right Cessation
- 1999-11-19 JP JP2000567065A patent/JP3389571B2/ja not_active Expired - Fee Related
- 1999-11-22 CA CA002290125A patent/CA2290125C/en not_active Expired - Fee Related
2000
- 2000-06-21 AR ARP000103080A patent/AR020573A1/es unknown
2001
- 2001-01-19 NO NO20010318A patent/NO20010318L/no unknown
- 2001-01-24 SE SE0100194A patent/SE516689C2/sv not_active IP Right Cessation
- 2001-01-25 FI FI20010154A patent/FI108538B/fi not_active IP Right Cessation
- 2001-02-23 IS IS5862A patent/IS5862A/is unknown
- 2001-03-13 AT AT0018501U patent/AT4366U1/de not_active IP Right Cessation
- 2001-10-26 ZA ZA200108855A patent/ZA200108855B/xx unknown
- 2001-11-06 US US10/012,025 patent/US6750358B2/en not_active Expired - Fee Related
- 2001-12-07 BG BG106190A patent/BG106190A/xx unknown

Also Published As

Publication number	Publication date
ITMI991579A1 (it)	2001-01-15
NZ514982A (en)	2004-01-30
IL145960A0 (en)	2002-07-25
PT1105382E (pt)	2002-07-31
KR100491369B1 (ko)	2005-05-24
BR9917367A (pt)	2002-03-05
HUP0103417A3 (en)	2003-01-28
GB2354240B (en)	2001-05-23
SE0100194D0 (sv)	2001-01-24
AT4366U1 (de)	2001-06-25
EA200101071A1 (ru)	2002-02-28
ITMI991579A0 (it)	1999-07-15
ATA904099A (de)	2002-05-15
AU1374800A (en)	2000-03-21
MXPA01010986A (es)	2002-06-04
CZ292174B6 (cs)	2003-08-13
AU2001100433B4 (en)	2002-01-17
WO2000011926A3 (en)	2000-06-29
US6750358B2 (en)	2004-06-15
CA2290125C (en)	2004-08-10
CN1356993A (zh)	2002-07-03
FI20010154L (fi)	2001-02-09
SE516689C2 (sv)	2002-02-12
TR200103700T2 (tr)	2002-05-21
US20020061925A1 (en)	2002-05-23
HK1047745A1 (en)	2003-03-07
EA002661B1 (ru)	2002-08-29
CH691304A5 (de)	2001-06-29
AT409960B (de)	2002-12-27
ES2172356T3 (es)	2002-09-16
CN1129593C (zh)	2003-12-03
SK18412001A3 (sk)	2002-05-09
SE0100194L (sv)	2001-04-25
WO2000011926A2 (en)	2000-03-09
KR20020011982A (ko)	2002-02-09
EP1105382A2 (en)	2001-06-13
GB0101508D0 (en)	2001-03-07
FI108538B (fi)	2002-02-15
ATE213237T1 (de)	2002-02-15
JP3389571B2 (ja)	2003-03-24
DE69900891D1 (de)	2002-03-21
PL345971A1 (en)	2002-01-14
EP1105382B1 (en)	2002-02-13
JP2002523432A (ja)	2002-07-30
GB2354240A (en)	2001-03-21
AR020573A1 (es)	2002-05-15
AU2001100433A4 (en)	2001-11-01
DE19983486C2 (de)	2002-09-05
NO20010318D0 (no)	2001-01-19
DE19983486T1 (de)	2001-10-18
SI1105382T1 (en)	2002-06-30
UA62023C2 (en)	2003-12-15
IS5862A (is)	2001-02-23
ZA200108855B (en)	2002-08-28
HUP0103417A2 (hu)	2002-01-28
CA2290125A1 (en)	2000-12-25
DK1105382T3 (da)	2002-05-27
BG106190A (en)	2002-08-30
HK1047745B (zh)	2004-09-10
CZ2001319A3 (en)	2001-05-16

Publication	Publication Date	Title
NO20015017D0 (no)	2001-10-15	Fremgangsmåte for fremstilling av citalopram
NO20010318D0 (no)	2001-01-19	Fremgangsmåte for fremstilling av Citalopram
NO20010319D0 (no)	2001-01-19	Fremgangsmåte for fremstilling av Citalopram
NO20011936L (no)	2001-06-01	Fremgangsmate for fremstilling av citalopram
NO20013185L (no)	2001-08-24	Fremgangsmate ved fremstilling av citalopram
NO20013943D0 (no)	2001-08-14	Fremgangsmate for fremstilling av Citalopram
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20013667D0 (no)	2001-07-26	Fremgangsmåte ved fremstilling av 5-cyanoftalid
NO20011272L (no)	2002-07-01	Fremgangsmåte for fremstilling av ren citalopram
NO20011271A (no)	2002-05-13	Fremgangsmåte for fremstilling av ren citalopram
NO20023928L (no)	2002-08-19	Fremgangsmåte ved fremstillingen av citalopram
NO20024007D0 (no)	2002-08-22	Fremgangsmåte ved fremstillingen av citalopram
NO20025423L (no)	2002-11-12	Fremgangsmate for fremstilling av Citalopram
NO20024180D0 (no)	2002-09-02	Fremgangsmåte ved fremstillingen av citalopram
NO20024213D0 (no)	2002-09-04	Fremgangsmåte ved fremstilling av citalopram
NO20003454L (no)	2000-07-04	FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO20021118D0 (no)	2002-03-06	Fremgangsmåte for fremstilling av citalopram
DK1228056T3 (da)	2005-01-24	Fremgangsmåde til fremstilling af citalopram
NO20024214D0 (no)	2002-09-04	Fremgangsmåte ved fremstilling av citalopram
NO20013995D0 (no)	2001-08-16	Fremgangsmate for fremstilling av L-sorbose
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20012811D0 (no)	2001-06-07	Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20020327D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20013044L (no)	2001-08-20	Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
SE9901814D0 (sv)	1999-05-16	Förfarande avseende framställning av granuler